3

PRIMARY DOCUMENT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: September 11, 2013
Period of Report: September 9, 2013
Accession Number: 0001237899-13-000048

View Document ↗ View on SEC.gov ↗